Hunan Er-Kang Pharmaceutical Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300267
  • 1d-1.95%
  • 1w-1.57%
  • 1m-4.20%
  • 1y-25.05%
ATH
  • ATH Price$21.21
  • ATH Date2015-06-02
  • % since ATH-88.17%
  • % to ATH745.18%
ATL
  • ATL Price$1.44
  • ATL Date2012-01-18
  • % from ATL74.73%
  • Last Low Price$2.13
  • Last Low Date2024-02-05
  • % From Last Low17.84%
IPO
  • IPO Price$23.00
  • % Current ROI USD-89.09%
  • ATH Price$21.21
  • % ROI ATH 147,677.69%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300267"]

Key Data [addtoany]

Current price $2.51
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $2.59/$2.51
Volume 16,938,300.00
Previous Close $2.56
52 Week High/Low $3.93/$2.08
Market Cap 5,177,125,888.00
P/E Ratio 125.5
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.012
$2.51
[addtoany]

Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.
Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol.
The company’s finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets.
Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products.
The company was founded in 2003 and is based in Liuyang, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity